Influenza Antiviral Drugs Market 2027 By Type, Treatment Type, Mechanism of Action, Vaccine Type, Routes of Administration, End Users and Geography | The Insight Partners

Influenza Antiviral Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Influenza A, Influenza B, Influenza C); Treatment Type (Medication, Chemoprophylaxis, Others); Mechanism of Action (Cap- dependent endonuclease inhibitor, Nuraminidase Inhibitor, Matrix-2 Protein Inhibitor, Viral Uncoatings Inhibitors, Immunomodulators); Vaccine Type (Quadrivalent, Trivalent ,Others); Routes of Administration (Oral, Parenteral, Others); End Users (Hospitals, Clinics, Specialty Clinics, Others) and Geography

Report Code: TIPRE00015600 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Influenza is a kind of viral infection which has a contagious nature that causes a upper respiratory tract infection and affects nose, throat as well as lungs. The symptoms usually starts from mild nature but can be life threatening it not treated in time. The more prone to infection are the people who have a weakened immune system or having age above 65 years. The symptoms of influenza includes, sweat, chills, sore throat, fever. The major category of drugs which are used in treatment of influenza include, antiviral and immunomodulatory agents.

MARKET DYNAMICS

The key market drivers for Influenza Antiviral Drugs Market Includes, increasing prevalence of influenza infection worldwide along with introduction of novel drug therapies and various treatment options are some factors which will drive market during the forecast period. However, high cost of treatment, expiration of patents and launching of generic drugs are some factors which will hamper market growth during the forecast period.

MARKET SCOPE

The "Influenza Antiviral Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Influenza Antiviral Drugs market with detailed market segmentation by type, treatment type, mechanism of action, vaccine type, route of administration, and end user. The Influenza Antiviral Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Influenza Antiviral Drugs Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Influenza Antiviral Drugs Market is segmented on the basis of type, treatment type, mechanism of action, vaccine type, route of administration, and end user. On the basis of type the market is segmented into, influenza, Influenza B, and Influenza C. On the basis of treatment type it is segmented as, medication, chemoprophylaxis and others. On the basis of mechanism of action the market is segmented as, cap- dependent endonuclease inhibitor,nuraminidase inhibitor, matrix-2 protein inhibitor. On the basis of vaccine type quadrivalent, trivalent and others. On the basis of route of administration the market is segmented as, oral, parenteral and others. And on the basis of end user the market is segmented as, hospitals, clinics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Influenza Antiviral Drugs Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Influenza Antiviral Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Influenza Antiviral Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Influenza Antiviral Drugs Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Influenza Antiviral Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Influenza Antiviral Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Aortic and Peripheral Vascular Interventional Therapy Product, market in the global market. Below mentioned is the list of few companies engaged in the Influenza Antiviral Drugs Market.

The report also includes the profiles of key players in Influenza Antiviral Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Sun Pharmaceuticals Industries, Ltd
  •   ADMA Biologics,Inc
  •   Shionogi Inc
  •   F. Hoffmann-La Roche Ltd
  •   Cipla Inc
  •   Glaxosmithkline Plc
  •   Teva Pharmaceutical Industries Ltd
  •   Novartis AG
  •   Sanofi
  •   AstraZeneca

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Antiviral Drugs Market - By Type
1.3.2 Influenza Antiviral Drugs Market - By Treatment Type
1.3.3 Influenza Antiviral Drugs Market - By Mechanism of Action
1.3.4 Influenza Antiviral Drugs Market - By Vaccine Type
1.3.5 Influenza Antiviral Drugs Market - By Routes of Administration
1.3.6 Influenza Antiviral Drugs Market - By End Users
1.3.7 Influenza Antiviral Drugs Market - By Region
1.3.7.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. INFLUENZA ANTIVIRAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. INFLUENZA ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. INFLUENZA ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INFLUENZA A, INFLUENZA B, INFLUENZA C
7.3.1. Overview
7.3.2. Influenza A, Influenza B, Influenza C Market Forecast and Analysis
8. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. MEDICATION, CHEMOPROPHYLAXIS, OTHERS
8.3.1. Overview
8.3.2. Medication, Chemoprophylaxis, Others Market Forecast and Analysis
9. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - MECHANISM OF ACTION
9.1. OVERVIEW
9.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CAP- DEPENDENT ENDONUCLEASE INHIBITOR
9.3.1. Overview
9.3.2. Cap- dependent endonuclease inhibitor Market Forecast and Analysis
9.3.3. Daloxavir Market
9.3.3.1. Overview
9.3.3.2. Daloxavir Market Forecast and Analysis
9.4. NURAMINIDASE INHIBITOR
9.4.1. Overview
9.4.2. Nuraminidase Inhibitor Market Forecast and Analysis
9.4.3. Oseltamivir Market
9.4.3.1. Overview
9.4.3.2. Oseltamivir Market Forecast and Analysis
9.4.4. Zanamivir Market
9.4.4.1. Overview
9.4.4.2. Zanamivir Market Forecast and Analysis
9.4.5. Peramivir Market
9.4.5.1. Overview
9.4.5.2. Peramivir Market Forecast and Analysis
9.5. MATRIX-2 PROTEIN INHIBITOR
9.5.1. Overview
9.5.2. Matrix-2 Protein Inhibitor Market Forecast and Analysis
9.5.3. Amantadine Market
9.5.3.1. Overview
9.5.3.2. Amantadine Market Forecast and Analysis
9.6. VIRAL UNCOATINGS INHIBITORS
9.6.1. Overview
9.6.2. Viral Uncoatings Inhibitors Market Forecast and Analysis
9.6.3. Rimantadine Market
9.6.3.1. Overview
9.6.3.2. Rimantadine Market Forecast and Analysis
9.7. IMMUNOMODULATORS
9.7.1. Overview
9.7.2. Immunomodulators Market Forecast and Analysis
9.7.3. Inosine Market
9.7.3.1. Overview
9.7.3.2. Inosine Market Forecast and Analysis
10. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
10.1. OVERVIEW
10.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
10.3. QUADRIVALENT, TRIVALENT ,OTHERS
10.3.1. Overview
10.3.2. Quadrivalent, Trivalent ,Others Market Forecast and Analysis
11. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTES OF ADMINISTRATION
11.1. OVERVIEW
11.2. ROUTES OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
11.3. ORAL, PARENTERAL, OTHERS
11.3.1. Overview
11.3.2. Oral, Parenteral, Others Market Forecast and Analysis
12. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USERS
12.1. OVERVIEW
12.2. END USERS MARKET FORECASTS AND ANALYSIS
12.3. HOSPITALS, CLINICS, SPECIALTY CLINICS, OTHERS
12.3.1. Overview
12.3.2. Hospitals, Clinics, Specialty Clinics, Others Market Forecast and Analysis

13. INFLUENZA ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Influenza Antiviral Drugs Market Overview
13.1.2 North America Influenza Antiviral Drugs Market Forecasts and Analysis
13.1.3 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.1.4 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.1.5 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.1.6 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.1.7 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.1.8 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.1.9 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.1.9.1 United States Influenza Antiviral Drugs Market
13.1.9.1.1 United States Influenza Antiviral Drugs Market by Type
13.1.9.1.2 United States Influenza Antiviral Drugs Market by Treatment Type
13.1.9.1.3 United States Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.1.4 United States Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.1.5 United States Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.1.6 United States Influenza Antiviral Drugs Market by End Users
13.1.9.2 Canada Influenza Antiviral Drugs Market
13.1.9.2.1 Canada Influenza Antiviral Drugs Market by Type
13.1.9.2.2 Canada Influenza Antiviral Drugs Market by Treatment Type
13.1.9.2.3 Canada Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.2.4 Canada Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.2.5 Canada Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.2.6 Canada Influenza Antiviral Drugs Market by End Users
13.1.9.3 Mexico Influenza Antiviral Drugs Market
13.1.9.3.1 Mexico Influenza Antiviral Drugs Market by Type
13.1.9.3.2 Mexico Influenza Antiviral Drugs Market by Treatment Type
13.1.9.3.3 Mexico Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.3.4 Mexico Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.3.5 Mexico Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.3.6 Mexico Influenza Antiviral Drugs Market by End Users
13.2. EUROPE
13.2.1 Europe Influenza Antiviral Drugs Market Overview
13.2.2 Europe Influenza Antiviral Drugs Market Forecasts and Analysis
13.2.3 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.2.4 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.2.5 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.2.6 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.2.7 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.2.8 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.2.9 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Influenza Antiviral Drugs Market
13.2.9.1.1 Germany Influenza Antiviral Drugs Market by Type
13.2.9.1.2 Germany Influenza Antiviral Drugs Market by Treatment Type
13.2.9.1.3 Germany Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.1.4 Germany Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.1.5 Germany Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.1.6 Germany Influenza Antiviral Drugs Market by End Users
13.2.9.2 France Influenza Antiviral Drugs Market
13.2.9.2.1 France Influenza Antiviral Drugs Market by Type
13.2.9.2.2 France Influenza Antiviral Drugs Market by Treatment Type
13.2.9.2.3 France Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.2.4 France Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.2.5 France Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.2.6 France Influenza Antiviral Drugs Market by End Users
13.2.9.3 Italy Influenza Antiviral Drugs Market
13.2.9.3.1 Italy Influenza Antiviral Drugs Market by Type
13.2.9.3.2 Italy Influenza Antiviral Drugs Market by Treatment Type
13.2.9.3.3 Italy Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.3.4 Italy Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.3.5 Italy Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.3.6 Italy Influenza Antiviral Drugs Market by End Users
13.2.9.4 Spain Influenza Antiviral Drugs Market
13.2.9.4.1 Spain Influenza Antiviral Drugs Market by Type
13.2.9.4.2 Spain Influenza Antiviral Drugs Market by Treatment Type
13.2.9.4.3 Spain Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.4.4 Spain Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.4.5 Spain Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.4.6 Spain Influenza Antiviral Drugs Market by End Users
13.2.9.5 United Kingdom Influenza Antiviral Drugs Market
13.2.9.5.1 United Kingdom Influenza Antiviral Drugs Market by Type
13.2.9.5.2 United Kingdom Influenza Antiviral Drugs Market by Treatment Type
13.2.9.5.3 United Kingdom Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.5.4 United Kingdom Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.5.5 United Kingdom Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.5.6 United Kingdom Influenza Antiviral Drugs Market by End Users
13.2.9.6 Rest of Europe Influenza Antiviral Drugs Market
13.2.9.6.1 Rest of Europe Influenza Antiviral Drugs Market by Type
13.2.9.6.2 Rest of Europe Influenza Antiviral Drugs Market by Treatment Type
13.2.9.6.3 Rest of Europe Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.6.4 Rest of Europe Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.6.5 Rest of Europe Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.6.6 Rest of Europe Influenza Antiviral Drugs Market by End Users
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Influenza Antiviral Drugs Market Overview
13.3.2 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis
13.3.3 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.3.4 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.3.5 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.3.6 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.3.7 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.3.8 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.3.9 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Influenza Antiviral Drugs Market
13.3.9.1.1 Australia Influenza Antiviral Drugs Market by Type
13.3.9.1.2 Australia Influenza Antiviral Drugs Market by Treatment Type
13.3.9.1.3 Australia Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.1.4 Australia Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.1.5 Australia Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.1.6 Australia Influenza Antiviral Drugs Market by End Users
13.3.9.2 China Influenza Antiviral Drugs Market
13.3.9.2.1 China Influenza Antiviral Drugs Market by Type
13.3.9.2.2 China Influenza Antiviral Drugs Market by Treatment Type
13.3.9.2.3 China Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.2.4 China Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.2.5 China Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.2.6 China Influenza Antiviral Drugs Market by End Users
13.3.9.3 India Influenza Antiviral Drugs Market
13.3.9.3.1 India Influenza Antiviral Drugs Market by Type
13.3.9.3.2 India Influenza Antiviral Drugs Market by Treatment Type
13.3.9.3.3 India Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.3.4 India Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.3.5 India Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.3.6 India Influenza Antiviral Drugs Market by End Users
13.3.9.4 Japan Influenza Antiviral Drugs Market
13.3.9.4.1 Japan Influenza Antiviral Drugs Market by Type
13.3.9.4.2 Japan Influenza Antiviral Drugs Market by Treatment Type
13.3.9.4.3 Japan Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.4.4 Japan Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.4.5 Japan Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.4.6 Japan Influenza Antiviral Drugs Market by End Users
13.3.9.5 South Korea Influenza Antiviral Drugs Market
13.3.9.5.1 South Korea Influenza Antiviral Drugs Market by Type
13.3.9.5.2 South Korea Influenza Antiviral Drugs Market by Treatment Type
13.3.9.5.3 South Korea Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.5.4 South Korea Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.5.5 South Korea Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.5.6 South Korea Influenza Antiviral Drugs Market by End Users
13.3.9.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market
13.3.9.6.1 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Type
13.3.9.6.2 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Treatment Type
13.3.9.6.3 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.6.4 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.6.5 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.6.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market by End Users
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Influenza Antiviral Drugs Market Overview
13.4.2 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis
13.4.3 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.4.4 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.4.5 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.4.6 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.4.7 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.4.8 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.4.9 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Influenza Antiviral Drugs Market
13.4.9.1.1 South Africa Influenza Antiviral Drugs Market by Type
13.4.9.1.2 South Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.1.3 South Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.1.4 South Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.1.5 South Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.1.6 South Africa Influenza Antiviral Drugs Market by End Users
13.4.9.2 Saudi Arabia Influenza Antiviral Drugs Market
13.4.9.2.1 Saudi Arabia Influenza Antiviral Drugs Market by Type
13.4.9.2.2 Saudi Arabia Influenza Antiviral Drugs Market by Treatment Type
13.4.9.2.3 Saudi Arabia Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.2.4 Saudi Arabia Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.2.5 Saudi Arabia Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.2.6 Saudi Arabia Influenza Antiviral Drugs Market by End Users
13.4.9.3 U.A.E Influenza Antiviral Drugs Market
13.4.9.3.1 U.A.E Influenza Antiviral Drugs Market by Type
13.4.9.3.2 U.A.E Influenza Antiviral Drugs Market by Treatment Type
13.4.9.3.3 U.A.E Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.3.4 U.A.E Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.3.5 U.A.E Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.3.6 U.A.E Influenza Antiviral Drugs Market by End Users
13.4.9.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market
13.4.9.4.1 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Type
13.4.9.4.2 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.4.3 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.4.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.4.5 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.4.6 Rest of Middle East and Africa Influenza Antiviral Drugs Market by End Users
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Influenza Antiviral Drugs Market Overview
13.5.2 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis
13.5.3 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.5.4 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.5.5 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.5.6 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.5.7 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.5.8 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.5.9 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Influenza Antiviral Drugs Market
13.5.9.1.1 Brazil Influenza Antiviral Drugs Market by Type
13.5.9.1.2 Brazil Influenza Antiviral Drugs Market by Treatment Type
13.5.9.1.3 Brazil Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.1.4 Brazil Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.1.5 Brazil Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.1.6 Brazil Influenza Antiviral Drugs Market by End Users
13.5.9.2 Argentina Influenza Antiviral Drugs Market
13.5.9.2.1 Argentina Influenza Antiviral Drugs Market by Type
13.5.9.2.2 Argentina Influenza Antiviral Drugs Market by Treatment Type
13.5.9.2.3 Argentina Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.2.4 Argentina Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.2.5 Argentina Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.2.6 Argentina Influenza Antiviral Drugs Market by End Users
13.5.9.3 Rest of South and Central America Influenza Antiviral Drugs Market
13.5.9.3.1 Rest of South and Central America Influenza Antiviral Drugs Market by Type
13.5.9.3.2 Rest of South and Central America Influenza Antiviral Drugs Market by Treatment Type
13.5.9.3.3 Rest of South and Central America Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.3.4 Rest of South and Central America Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.3.5 Rest of South and Central America Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.3.6 Rest of South and Central America Influenza Antiviral Drugs Market by End Users

14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

15. INFLUENZA ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
15.1. SUN PHARMACEUTICAL INDUSTRIES LTD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. ADMA BIOLOGICS, INC
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. SHIONOGI INC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. F. HOFFMANN-LA ROCHE LTD
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. CIPLA INC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. GLAXOSMITHKLINE PLC
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVARTIS AG
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. SANOFI
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. ASTRAZENECA
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies

1. Sun Pharmaceutical Industries Ltd
2. ADMA Biologics, Inc
3. Shionogi Inc
4. F. Hoffmann-La Roche Ltd
5. Cipla Inc
6. GlaxoSmithKline Plc
7. Teva Pharmaceutical Industries Ltd
8. Novartis AG
9. Sanofi
10. AstraZeneca
TIPRE00015600
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking